Latest period
$6.63B
YoY change
-2.2%
5Y CAGR
+8.1%
Peak year (2024)
$6.48B
Latest annual
$6.34B
Total Assets history chart for DexCom (DXCM) from 2000 to 2025
Latest: $6.34B
Total Assets growth chart for DexCom (DXCM) from 2000 to 2025
Latest: -2.2%
Total Assets history table for DexCom (DXCM) from 2000 to 2025
| 2025 | $6.34B | -2.2% | −$144.60M | ||
| 2024 | $6.48B | +3.5% | +$220.00M | ||
| 2023 | $6.26B | +16.2% | +$872.80M | ||
| 2022 | $5.39B | +9.3% | +$458.40M | ||
| 2021 | $4.93B | +15.0% | +$642.80M | ||
| 2020 | $4.29B | +79.1% | +$1.90B | ||
| 2019 | $2.40B | +25.0% | +$479.00M | ||
| 2018 | $1.92B | +111.9% | +$1.01B | ||
| 2017 | $904.10M | +124.5% | +$501.30M | ||
| 2016 | $402.80M | +37.9% | +$110.80M | ||
| 2015 | $292.00M | +58.2% | +$107.40M | ||
| 2014 | $184.60M | +50.7% | +$62.10M | ||
| 2013 | $122.50M | +15.6% | +$16.50M | ||
| 2012 | $106.00M | -12.0% | −$14.47M | ||
| 2011 | $120.47M | +56.1% | +$43.31M | ||
| 2010 | $77.16M | +64.4% | +$30.22M | ||
| 2009 | $46.95M | +5.8% | +$2.58M | ||
| 2008 | $44.37M | -42.6% | −$32.89M | ||
| 2007 | $77.26M | +19.7% | +$12.71M | ||
| 2006 | $64.55M | +13.8% | +$7.83M | ||
| 2005 | $56.73M | +93.2% | +$27.37M | ||
| 2004 | $29.36M | +41.4% | +$8.59M | ||
| 2003 | $20.77M | — | — | ||
| 2001 | $8.64M | -39.8% | −$5.72M | ||
| 2000 | $14.36M | — | — |
- 2025$6.34B-2.2%
- 2024$6.48B+3.5%
- 2023$6.26B+16.2%
- 2022$5.39B+9.3%
- 2021$4.93B+15.0%
- 2020$4.29B+79.1%
- 2019$2.40B+25.0%
- 2018$1.92B+111.9%
- 2017$904.10M+124.5%
- 2016$402.80M+37.9%
- 2015$292.00M+58.2%
- 2014$184.60M+50.7%
- 2013$122.50M+15.6%
- 2012$106.00M-12.0%
- 2011$120.47M+56.1%
- 2010$77.16M+64.4%
- 2009$46.95M+5.8%
- 2008$44.37M-42.6%
- 2007$77.26M+19.7%
- 2006$64.55M+13.8%
- 2005$56.73M+93.2%
- 2004$29.36M+41.4%
- 2003$20.77M—
- 2001$8.64M-39.8%
- 2000$14.36M—
Total Assets values are taken from DexCom's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's latest reported total assets is $6.63B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of DexCom (DXCM) total assets is $6.34B – edged down 2.2% year-over-year.
Through 2020–2025 (5 years), DexCom total assets delivered a +8.1% annualised rate; with mixed annual results across the window.
DexCom total assets edged down from $6.48B in 2024 to $6.34B in 2025, a 2.2% drawdown.
The highest annual total assets of $6.48B was reported in 2024. The lowest in the available history was $8.64M in 2001.
DexCom Total Assets by Year
DexCom Total Assets 2025: $6.34B
2025's total assets for DexCom came in at $6.34B, edged down 2.2% below 2024.
DexCom Total Assets 2024: $6.48B
DexCom posted total assets of $6.48B in 2024, edged up 3.5% from 2023. This figure represents the highest annual value in the available history.
DexCom Total Assets 2023: $6.26B
In 2023, DexCom reported total assets of $6.26B, grew 16.2% from 2022.
DexCom Total Assets 2022: $5.39B
DexCom total assets in 2022 was $5.39B, grew 9.3% from 2021.
DexCom Total Assets 2021: $4.93B
DexCom total assets in 2021 was $4.93B.
See more financial history for DexCom (DXCM).
Sector peers by Total Assets
Healthcare peers of DexCom (DXCM), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation